title: Quality of life and changes in symptom relief in patients with acute uncomplicated cystitis treated with antibiotics: a prospective, open-label, multicenter, observational study.
abstract: The purpose of this study was to investigate the effect of ciprofloxacin treatment on quality of life and symptom improvement in patients with simple cystitis. Between January 2010 and December 2010, ciprofloxacin was administered twice daily for 5 days, and changes in the patients' symptoms, the therapeutic effects, and changes in the Korean version of the Urinary Tract Infection Symptoms Assessment (UTISA) score were evaluated. Patients were classified into two groups according to the self-reported degree of symptom improvement. Significant improvement was noted in symptoms such as frequency, urgency, dysuria, tenesmus, lower abdominal discomfort, back pain, and gross hematuria. The treatment success group comprised 249 patients and the treatment failure group comprised 45 patients. Baseline frequency and urgency, tenesmus, and lower abdominal discomfort were worse in the treatment failure group, although the difference was significant only for frequency (p = 0.029) and urgency (p = 0.028). All UTISA subcategory scores showed improvement in the treatment success group, and the median time to symptom improvement was 2.40 days. In the treatment failure group, some UTISA subcategory scores showed significant improvement, including those for dysuria (1.67 to 0.89), tenesmus (1.76 to 1.08), and gross hematuria (0.80 to 0.21), although significant improvement in frequency, urgency, lower abdominal discomfort, and back pain was not observed. The UTISA questionnaire was useful in reflecting the severity of simple cystitis symptoms. Frequency, urgency, lower abdominal discomfort, and back pain were not adequately improved in the treatment failure group, with frequency and urgency being predisposing factors for treatment failure.
authors: Department of Urology, Korea University Hospital, Seoul, Korea.
authors: H
authors: H
authors: Choi
authors: Y H
authors: YH
authors: Kim
authors: J H
authors: JH
authors: Bae
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002939:Ciprofloxacin / Q000008:administration & dosage*; D003556:Cystitis / Q000188:drug therapy* / Q000473:pathology* / Q000523:psychology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011788:Quality of Life / Q000523:psychology*; D012720:Severity of Illness Index; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin
references: Clin Infect Dis. 1994 Jan;18(1):1-10; quiz 11-2
references: 8054415
references: Am J Public Health. 1990 Mar;80(3):331-3
references: 2305919
references: West J Med. 2002 Jan;176(1):51-5
references: 11788540
references: Am J Med. 1993 Mar 22;94(3A):89S-96S
references: 8452189
references: Infect Dis Clin North Am. 1997 Sep;11(3):551-81
references: 9378923
references: Int J Antimicrob Agents. 2004 Mar;23 Suppl 1:S35-40
references: 15037327
references: Dis Mon. 2003 Feb;49(2):129-47
references: 12601342
references: Med Care. 1992 Jun;30(6):473-83
references: 1593914
references: J Am Board Fam Pract. 2000 Nov-Dec;13(6):392-7
references: 11117334
references: BJU Int. 2005 Aug;96(3):350-9
references: 16042729
references: Curr Med Res Opin. 2005 Aug;21(8):1241-50
references: 16083534
references: Clin Drug Investig. 2004;24(1):55-60
references: 17516691
references: Expert Opin Pharmacother. 2001 Aug;2(8):1227-37
references: 11584990
references: Clin Obstet Gynecol. 2003 Dec;46(4):811-23
references: 14595223
references: Postgrad Med J. 2003 Aug;79(934):428-32
references: 12954951
references: Dis Mon. 2003 Feb;49(2):53-70
references: 12601337
references: MedGenMed. 2003 Jul 01;5(3):1
references: 14600638
references: Health Qual Life Outcomes. 2005 Jul 27;3:45
references: 16048650
references: Physiol Rev. 1994 Jan;74(1):95-138
references: 8295936
references: Br J Obstet Gynaecol. 1997 Dec;104(12):1374-9
references: 9422015